Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
This report aims to provide a comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Drug Delivery. This report contains market size and forecasts of Liposome Drug Delivery in global, including the following market information:
Global Liposome Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Liposome Drug Delivery Market Sales, 2018-2023, 2024-2029, (K Vial)
Global top five Liposome Drug Delivery companies in 2022 (%)
The global Liposome Drug Delivery market was valued at US$ 3842.1 million in 2022 and is projected to reach US$ 8627 million by 2029, at a CAGR of 12.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.
We surveyed the Liposome Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposome Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Vial)
Global Liposome Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Global Liposome Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Vial)
Global Liposome Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Global Liposome Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Vial)
Global Liposome Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposome Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Liposome Drug Delivery revenues share in global market, 2022 (%)
Key companies Liposome Drug Delivery sales in global market, 2018-2023 (Estimated), (K Vial)
Key companies Liposome Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liposome Drug Delivery, market overview.
Chapter 2: Global Liposome Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liposome Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Liposome Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Liposome Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposome Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposome Drug Delivery Overall Market Size
2.1 Global Liposome Drug Delivery Market Size: 2022 VS 2029
2.2 Global Liposome Drug Delivery Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Liposome Drug Delivery Sales: 2018-2029
3 Company Landscape
3.1 Top Liposome Drug Delivery Players in Global Market
3.2 Top Global Liposome Drug Delivery Companies Ranked by Revenue
3.3 Global Liposome Drug Delivery Revenue by Companies
3.4 Global Liposome Drug Delivery Sales by Companies
3.5 Global Liposome Drug Delivery Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Liposome Drug Delivery Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Liposome Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposome Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Liposome Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Liposome Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Liposome Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Liposomal Doxorubicin
4.1.3 Liposomal Amphoteracin B
4.1.4 Liposomal Paclitaxel
4.1.5 Others
4.2 By Type - Global Liposome Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Liposome Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Liposome Drug Delivery Revenue, 2024-2029
4.2.3 By Type - Global Liposome Drug Delivery Revenue Market Share, 2018-2029
4.3 By Type - Global Liposome Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Liposome Drug Delivery Sales, 2018-2023
4.3.2 By Type - Global Liposome Drug Delivery Sales, 2024-2029
4.3.3 By Type - Global Liposome Drug Delivery Sales Market Share, 2018-2029
4.4 By Type - Global Liposome Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liposome Drug Delivery Market Size, 2022 & 2029
5.1.2 Fungal Infection Therapy
5.1.3 Cancer & Tumor Therapy
5.1.4 Others
5.2 By Application - Global Liposome Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Liposome Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Liposome Drug Delivery Revenue, 2024-2029
5.2.3 By Application - Global Liposome Drug Delivery Revenue Market Share, 2018-2029
5.3 By Application - Global Liposome Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Liposome Drug Delivery Sales, 2018-2023
5.3.2 By Application - Global Liposome Drug Delivery Sales, 2024-2029
5.3.3 By Application - Global Liposome Drug Delivery Sales Market Share, 2018-2029
5.4 By Application - Global Liposome Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Liposome Drug Delivery Market Size, 2022 & 2029
6.2 By Region - Global Liposome Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Liposome Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Liposome Drug Delivery Revenue, 2024-2029
6.2.3 By Region - Global Liposome Drug Delivery Revenue Market Share, 2018-2029
6.3 By Region - Global Liposome Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Liposome Drug Delivery Sales, 2018-2023
6.3.2 By Region - Global Liposome Drug Delivery Sales, 2024-2029
6.3.3 By Region - Global Liposome Drug Delivery Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Liposome Drug Delivery Revenue, 2018-2029
6.4.2 By Country - North America Liposome Drug Delivery Sales, 2018-2029
6.4.3 US Liposome Drug Delivery Market Size, 2018-2029
6.4.4 Canada Liposome Drug Delivery Market Size, 2018-2029
6.4.5 Mexico Liposome Drug Delivery Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Liposome Drug Delivery Revenue, 2018-2029
6.5.2 By Country - Europe Liposome Drug Delivery Sales, 2018-2029
6.5.3 Germany Liposome Drug Delivery Market Size, 2018-2029
6.5.4 France Liposome Drug Delivery Market Size, 2018-2029
6.5.5 U.K. Liposome Drug Delivery Market Size, 2018-2029
6.5.6 Italy Liposome Drug Delivery Market Size, 2018-2029
6.5.7 Russia Liposome Drug Delivery Market Size, 2018-2029
6.5.8 Nordic Countries Liposome Drug Delivery Market Size, 2018-2029
6.5.9 Benelux Liposome Drug Delivery Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Liposome Drug Delivery Revenue, 2018-2029
6.6.2 By Region - Asia Liposome Drug Delivery Sales, 2018-2029
6.6.3 China Liposome Drug Delivery Market Size, 2018-2029
6.6.4 Japan Liposome Drug Delivery Market Size, 2018-2029
6.6.5 South Korea Liposome Drug Delivery Market Size, 2018-2029
6.6.6 Southeast Asia Liposome Drug Delivery Market Size, 2018-2029
6.6.7 India Liposome Drug Delivery Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Liposome Drug Delivery Revenue, 2018-2029
6.7.2 By Country - South America Liposome Drug Delivery Sales, 2018-2029
6.7.3 Brazil Liposome Drug Delivery Market Size, 2018-2029
6.7.4 Argentina Liposome Drug Delivery Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Liposome Drug Delivery Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Liposome Drug Delivery Sales, 2018-2029
6.8.3 Turkey Liposome Drug Delivery Market Size, 2018-2029
6.8.4 Israel Liposome Drug Delivery Market Size, 2018-2029
6.8.5 Saudi Arabia Liposome Drug Delivery Market Size, 2018-2029
6.8.6 UAE Liposome Drug Delivery Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Company Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Liposome Drug Delivery Major Product Offerings
7.1.4 Gilead Sciences Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.1.5 Gilead Sciences Key News & Latest Developments
7.2 Pacira
7.2.1 Pacira Company Summary
7.2.2 Pacira Business Overview
7.2.3 Pacira Liposome Drug Delivery Major Product Offerings
7.2.4 Pacira Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.2.5 Pacira Key News & Latest Developments
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Company Summary
7.3.2 Sun Pharmaceutical Business Overview
7.3.3 Sun Pharmaceutical Liposome Drug Delivery Major Product Offerings
7.3.4 Sun Pharmaceutical Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.3.5 Sun Pharmaceutical Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Liposome Drug Delivery Major Product Offerings
7.4.4 Johnson & Johnson Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Luye Pharma
7.5.1 Luye Pharma Company Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Liposome Drug Delivery Major Product Offerings
7.5.4 Luye Pharma Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.5.5 Luye Pharma Key News & Latest Developments
7.6 Sigma-Tau
7.6.1 Sigma-Tau Company Summary
7.6.2 Sigma-Tau Business Overview
7.6.3 Sigma-Tau Liposome Drug Delivery Major Product Offerings
7.6.4 Sigma-Tau Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.6.5 Sigma-Tau Key News & Latest Developments
7.7 Ipsen (Onivyde)
7.7.1 Ipsen (Onivyde) Company Summary
7.7.2 Ipsen (Onivyde) Business Overview
7.7.3 Ipsen (Onivyde) Liposome Drug Delivery Major Product Offerings
7.7.4 Ipsen (Onivyde) Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.7.5 Ipsen (Onivyde) Key News & Latest Developments
7.8 CSPC
7.8.1 CSPC Company Summary
7.8.2 CSPC Business Overview
7.8.3 CSPC Liposome Drug Delivery Major Product Offerings
7.8.4 CSPC Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.8.5 CSPC Key News & Latest Developments
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Company Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Liposome Drug Delivery Major Product Offerings
7.9.4 Teva Pharmaceutical Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.9.5 Teva Pharmaceutical Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Liposome Drug Delivery Major Product Offerings
7.10.4 Novartis Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Fudan-Zhangjiang
7.11.1 Fudan-Zhangjiang Company Summary
7.11.2 Fudan-Zhangjiang Liposome Drug Delivery Business Overview
7.11.3 Fudan-Zhangjiang Liposome Drug Delivery Major Product Offerings
7.11.4 Fudan-Zhangjiang Liposome Drug Delivery Sales and Revenue in Global (2018-2023)
7.11.5 Fudan-Zhangjiang Key News & Latest Developments
8 Global Liposome Drug Delivery Production Capacity, Analysis
8.1 Global Liposome Drug Delivery Production Capacity, 2018-2029
8.2 Liposome Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposome Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Liposome Drug Delivery Supply Chain Analysis
10.1 Liposome Drug Delivery Industry Value Chain
10.2 Liposome Drug Delivery Upstream Market
10.3 Liposome Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liposome Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Liposome Drug Delivery in Global Market
Table 2. Top Liposome Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Liposome Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Liposome Drug Delivery Revenue Share by Companies, 2018-2023
Table 5. Global Liposome Drug Delivery Sales by Companies, (K Vial), 2018-2023
Table 6. Global Liposome Drug Delivery Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Liposome Drug Delivery Price (2018-2023) & (USD/Vial)
Table 8. Global Manufacturers Liposome Drug Delivery Product Type
Table 9. List of Global Tier 1 Liposome Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposome Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Liposome Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Liposome Drug Delivery Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Liposome Drug Delivery Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Liposome Drug Delivery Sales (K Vial), 2018-2023
Table 15. By Type - Global Liposome Drug Delivery Sales (K Vial), 2024-2029
Table 16. By Application ? Global Liposome Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Liposome Drug Delivery Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Liposome Drug Delivery Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Liposome Drug Delivery Sales (K Vial), 2018-2023
Table 20. By Application - Global Liposome Drug Delivery Sales (K Vial), 2024-2029
Table 21. By Region ? Global Liposome Drug Delivery Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Liposome Drug Delivery Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Liposome Drug Delivery Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Liposome Drug Delivery Sales (K Vial), 2018-2023
Table 25. By Region - Global Liposome Drug Delivery Sales (K Vial), 2024-2029
Table 26. By Country - North America Liposome Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Liposome Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Liposome Drug Delivery Sales, (K Vial), 2018-2023
Table 29. By Country - North America Liposome Drug Delivery Sales, (K Vial), 2024-2029
Table 30. By Country - Europe Liposome Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Liposome Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Liposome Drug Delivery Sales, (K Vial), 2018-2023
Table 33. By Country - Europe Liposome Drug Delivery Sales, (K Vial), 2024-2029
Table 34. By Region - Asia Liposome Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Liposome Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Liposome Drug Delivery Sales, (K Vial), 2018-2023
Table 37. By Region - Asia Liposome Drug Delivery Sales, (K Vial), 2024-2029
Table 38. By Country - South America Liposome Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Liposome Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Liposome Drug Delivery Sales, (K Vial), 2018-2023
Table 41. By Country - South America Liposome Drug Delivery Sales, (K Vial), 2024-2029
Table 42. By Country - Middle East & Africa Liposome Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Liposome Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Liposome Drug Delivery Sales, (K Vial), 2018-2023
Table 45. By Country - Middle East & Africa Liposome Drug Delivery Sales, (K Vial), 2024-2029
Table 46. Gilead Sciences Company Summary
Table 47. Gilead Sciences Liposome Drug Delivery Product Offerings
Table 48. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 49. Gilead Sciences Key News & Latest Developments
Table 50. Pacira Company Summary
Table 51. Pacira Liposome Drug Delivery Product Offerings
Table 52. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 53. Pacira Key News & Latest Developments
Table 54. Sun Pharmaceutical Company Summary
Table 55. Sun Pharmaceutical Liposome Drug Delivery Product Offerings
Table 56. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 57. Sun Pharmaceutical Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Liposome Drug Delivery Product Offerings
Table 60. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Luye Pharma Company Summary
Table 63. Luye Pharma Liposome Drug Delivery Product Offerings
Table 64. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 65. Luye Pharma Key News & Latest Developments
Table 66. Sigma-Tau Company Summary
Table 67. Sigma-Tau Liposome Drug Delivery Product Offerings
Table 68. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 69. Sigma-Tau Key News & Latest Developments
Table 70. Ipsen (Onivyde) Company Summary
Table 71. Ipsen (Onivyde) Liposome Drug Delivery Product Offerings
Table 72. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 73. Ipsen (Onivyde) Key News & Latest Developments
Table 74. CSPC Company Summary
Table 75. CSPC Liposome Drug Delivery Product Offerings
Table 76. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 77. CSPC Key News & Latest Developments
Table 78. Teva Pharmaceutical Company Summary
Table 79. Teva Pharmaceutical Liposome Drug Delivery Product Offerings
Table 80. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 81. Teva Pharmaceutical Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Liposome Drug Delivery Product Offerings
Table 84. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Fudan-Zhangjiang Company Summary
Table 87. Fudan-Zhangjiang Liposome Drug Delivery Product Offerings
Table 88. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2018-2023)
Table 89. Fudan-Zhangjiang Key News & Latest Developments
Table 90. Liposome Drug Delivery Production Capacity (K Vial) of Key Manufacturers in Global Market, 2021-2023 (K Vial)
Table 91. Global Liposome Drug Delivery Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Liposome Drug Delivery Production by Region, 2018-2023 (K Vial)
Table 93. Global Liposome Drug Delivery Production by Region, 2024-2029 (K Vial)
Table 94. Liposome Drug Delivery Market Opportunities & Trends in Global Market
Table 95. Liposome Drug Delivery Market Drivers in Global Market
Table 96. Liposome Drug Delivery Market Restraints in Global Market
Table 97. Liposome Drug Delivery Raw Materials
Table 98. Liposome Drug Delivery Raw Materials Suppliers in Global Market
Table 99. Typical Liposome Drug Delivery Downstream
Table 100. Liposome Drug Delivery Downstream Clients in Global Market
Table 101. Liposome Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Liposome Drug Delivery Segment by Type in 2022
Figure 2. Liposome Drug Delivery Segment by Application in 2022
Figure 3. Global Liposome Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Liposome Drug Delivery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Liposome Drug Delivery Revenue, 2018-2029 (US$, Mn)
Figure 7. Liposome Drug Delivery Sales in Global Market: 2018-2029 (K Vial)
Figure 8. The Top 3 and 5 Players Market Share by Liposome Drug Delivery Revenue in 2022
Figure 9. By Type - Global Liposome Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Liposome Drug Delivery Revenue Market Share, 2018-2029
Figure 11. By Type - Global Liposome Drug Delivery Sales Market Share, 2018-2029
Figure 12. By Type - Global Liposome Drug Delivery Price (USD/Vial), 2018-2029
Figure 13. By Application - Global Liposome Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Liposome Drug Delivery Revenue Market Share, 2018-2029
Figure 15. By Application - Global Liposome Drug Delivery Sales Market Share, 2018-2029
Figure 16. By Application - Global Liposome Drug Delivery Price (USD/Vial), 2018-2029
Figure 17. By Region - Global Liposome Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Liposome Drug Delivery Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Liposome Drug Delivery Revenue Market Share, 2018-2029
Figure 20. By Region - Global Liposome Drug Delivery Sales Market Share, 2018-2029
Figure 21. By Country - North America Liposome Drug Delivery Revenue Market Share, 2018-2029
Figure 22. By Country - North America Liposome Drug Delivery Sales Market Share, 2018-2029
Figure 23. US Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Liposome Drug Delivery Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Liposome Drug Delivery Sales Market Share, 2018-2029
Figure 28. Germany Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 29. France Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Liposome Drug Delivery Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Liposome Drug Delivery Sales Market Share, 2018-2029
Figure 37. China Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 41. India Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Liposome Drug Delivery Revenue Market Share, 2018-2029
Figure 43. By Country - South America Liposome Drug Delivery Sales Market Share, 2018-2029
Figure 44. Brazil Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Liposome Drug Delivery Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Liposome Drug Delivery Sales Market Share, 2018-2029
Figure 48. Turkey Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Liposome Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 52. Global Liposome Drug Delivery Production Capacity (K Vial), 2018-2029
Figure 53. The Percentage of Production Liposome Drug Delivery by Region, 2022 VS 2029
Figure 54. Liposome Drug Delivery Industry Value Chain
Figure 55. Marketing Channels
